gr 127935 has been researched along with 5-chloro-2,3-dihydro-6-(4-methylpiperazin-1-yl)-1-(4-(pyridin-4-yl)naphth-1-ylaminocarbonyl)-1h-indole in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, LJ; Harrington, FP; Hopley, SC; Scott, CM; Ward, SE; Watson, JM | 1 |
1 other study(ies) available for gr 127935 and 5-chloro-2,3-dihydro-6-(4-methylpiperazin-1-yl)-1-(4-(pyridin-4-yl)naphth-1-ylaminocarbonyl)-1h-indole
| Article | Year |
|---|---|
Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.
Topics: Animals; Binding, Competitive; Cerebral Cortex; CHO Cells; Cricetinae; Cricetulus; In Vitro Techniques; Piperazines; Quinolines; Radioligand Assay; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Structure-Activity Relationship | 2005 |